Véronique Mansat‐De Mas

Impact of TET2 mutations on response rate to azacitidine in myelodysplastic syndromes and low blast count acute myeloid leukemias

Raphaël Itzykson, Olivier Kosmider, Thomas Cluzeau et al. · Leukemia · 2011 · 464 citations

Hematological Malignancy, Medicine, Mixed-phenotype Acute Leukemia +10

Human acute myelogenous leukemia stem cells are rare and heterogeneous when assayed in NOD/SCID/IL2Rγc-deficient mice

Jean‐Emmanuel Sarry, Kathleen M. Murphy, Robin Perry et al. · Journal of Clinical Investigation · 2010 · 380 citations

Mixed-phenotype Acute Leukemia, Immunology, Stem Cell Biology +16

Antileukemic activity of rapamycin in acute myeloid leukemia

Christian Récher, Odile Beyne‐Rauzy, Cécile Demur et al. · Blood · 2004 · 295 citations

TET2 mutation is an independent favorable prognostic factor in myelodysplastic syndromes (MDSs)

Olivier Kosmider, Véronique Gelsi‐Boyer, Meyling Cheok et al. · Blood · 2009 · 269 citations

Myeloid cell differentiation arrest by miR-125b-1 in myelodysplasic syndrome and acute myeloid leukemia with the t(2;11)(p21;q23) translocation

Marina Bousquet, Cathy Quelen, Roberto Rosati et al. · The Journal of Experimental Medicine · 2008 · 248 citations · Full text